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Summary
Background: Treatment of bifurcation lesion with a drug-eluting stent (DES) remains
problematic. The purpose of this study was to investigate an appropriate treatment
strategy for bifurcation lesion with a Sirolimus-eluting stent (SES).
Method: One-hundred-forty-one patients with 169 bifurcation lesions were treated
at three centers in Japan using a Sirolimus-eluting stent. Forty-six lesions (39
patients) were treated on side branches, and provisional stenting was performed
in these cases. We evaluated the angiographic results and clinical outcomes with
this strategy. Patients with acute myocardial infarction were excluded.
Result: After a follow-up period of 184± 65 days, there were no deaths or myocar-
dial infarction (MI), and only one (2.0%) target lesion revascularization (TLR). The
strategies used for side-branch treatment were balloon only (83.7%) and T or Mod-
iﬁed T stent (16.3%). The ﬁnal kissing balloon technique was performed on 53.4%
overall. In patients with a 6-month follow-up angiogram who had 25 bifurcation
T bifurcation lesions, 6 LCX-OM lesions, 13 LAD-Dx lesions,lesions (including 5 LM
and 1 RCA lesion) that were treated with balloon only, the percent diameter steno-
sis (%DS) of the side branch at follow-up was similar to that after the procedure
(47.2± 34.4% vs. 46.4± 24.1%).
∗ Corresponding author at: Fukuoka University School of Medicine, Department of Cardiology, 7-45-1 Nanakuma, Jonan-ku,
ukuoka 814-0180, Japan. Tel.: +81 92 801 1011; fax: +81 92 865 2692.
E-mail address: saku-k@fukuoka-u.ac.jp (K. Saku).
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Conclusions: In the treatment of bifurcation lesions using a SES, the results of pro-
visional stenting for the side branch are acceptable. Percent DS of the side branch
remained unchanged over time after PCI.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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An angiographic core laboratory at Fukuoka Uni-
versity Hospital analyzed all procedural and© 2008 Japanese Colleg
reserved.
Introduction
Since the advent of the bare metal stent (BMS),
it has been reported that the treatment strategy
of stenting in both branches does not improve the
clinical outcome [1—3].
In comparative studies, the Sirolimus-eluting
stent (SES) and Paclitaxel-eluting stent (PES) have
been established as being safe and effective for
reducing in-stent neointimal hyperplasia and clin-
ical event rates compared to BMS [4—9]. However,
the appropriate treatment strategy for bifurca-
tion lesions is still a challenging area. There is a
great need for a simple strategy for bifurcation
lesions with stenting of the main branch and pro-
visional side-branch stenting [10—14]. In this study,
we examined the value of provisional stenting for
side branches using SES based on the clinical out-
comes and an analysis of side-branch stenosis by
quantitative coronary angiogram (QCA).
Methods
Patients and study design
One-hundred-sixty-nine lesions (141 patients) with
side branches were treated with SESs at Fukuoka
University Hospital, Fukuoka University Chikushi
Hospital, and Fukuoka White Cross Hospital
between August 2004 and December 2006. Side-
branch treatment was performed for 46 lesions
(39 patients), and these were considered in this
study. Patients with acute myocardial infarction
(MI) within 24 h after the onset were excluded from
this study. When the branches were separated from
a lesion of the main branch by less than 3.0mm, and
the diameter of the branch was more than 1.5mm,
we deﬁned this lesion as a side-branch lesion. The
diagnosis of MI was deﬁned either as the devel-
opment of pathological Q waves in at least two
contiguous leads with or without elevated cardiac
enzymes, or in the absence of pathological Q waves
as an elevation in creatinine kinase levels to more
than twice the upper limit of normal in the presence
of an elevated creatinine kinase-MB level.
We studied the baseline patient and lesion char-
acteristics, interventional procedures and clinical
p
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mvents (death, MI, target lesion revascularization
TLR), and stent thrombosis) at 6 months. We
lso analyzed 25 bifurcation lesions with follow-up
oronary angiogram (CAG) by QCA. Stent throm-
osis was deﬁned as an acute coronary syndrome
ith angiographic documentation of vessel occlu-
ion or thrombus within or adjacent to a previously
tented segment. In the absence of angiography,
tent thrombosis could be conﬁrmed by acute MI
n the distribution of the treated vessel or death
esulting from cardiac causes within 30 days. The
rotocol was approved by the respective institu-
ional ethics committees.
rocedure
asically, provisional stenting was performed for
ide-branch treatment. SES implantation for the
ain branch was performed when the percent
iameter stenosis (%DS) of the lesion was more than
0% and myocardial ischemia was documented in
he target vessel area by a non-invasive method.
he endpoint of the procedure was TIMI 3 angio-
raphic %DS < 10 and no major dissection that could
ompromise the ﬂow of the main vessel. Ticlopidine
n addition to aspirin were prescribed for at least 6
onths.
ollow-up
linical follow-up information was obtained by tele-
hone contact or by reviewing hospital records.
uring follow-up, coronary angiography was per-
ormed routinely in Japan. TLR at follow-up was
erformed when angiographic %DS of the target
esion was more than 50% and myocardial ischemia
as documented in the target vessel area by non-
nvasive testing.
uantitative coronary angiographic
valuationost-procedural angiographic images using CMS-
FT (MEDIS, The Netherlands). The target lesion
as deﬁned as the stented lesion and 5mm proxi-
al and 5mm distal to the edge of the stent.
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Table 1 Patient characteristics
Overall (n = 39)
Age (year) 65.6± 11.4
Male (%) 80.4
DM (%) 27.8
Hypertension (%) 71.7
Hyperlipidemia (%) 67.4
UAP (%) 35.6
Prior MI (%) 53.3
Prior CABG (%) 6.7
Hemodialysis (%) 0
DM, diabetes mellitus; UAP, unstable angina pectoris; MI,
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trovisional stenting with drug-eluting stent for bifu
tatistical analysis
ll statistical analyses were performed using the
tatistical Analysis System (SAS) Software Pack-
ge (Ver. 9.1, SAS Institute Inc., Cary, NC, USA)
t Fukuoka University (Fukuoka, Japan). Data are
resented as the mean± standard deviation. Signif-
cant changes in percent diameter stenosis during
ollow-up post-procedure were examined by the
ilcoxon signed-rank test using Procedure UNIVARI-
TE. All P values are two-tailed. The signiﬁcance
evel was considered to be 5% unless indicated oth-
rwise.
esults
haracteristics of patients and lesions
aseline patient characteristics are shown in
able 1. The patients’ mean age was 65.6 years,
0.4% were male and 27.8% had diabetes mellitus.
ig. 1 shows the lesion prevalence according to the
ifurcation type using the Duke classiﬁcation: 30.6%
f the lesions were type D. Regarding the bifurca-
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Figure 1 Bifurcatiomyocardial infarction; CABG, coronary artery bypass
grafting.
ion location, LAD-diagonal (DX), LAD-LCX, LCX-OM,
nd right posterior descending artery-postero lat-
ral segment artery bifurcation accounted for
7.1%, 22.8%, 17.1%, and 2.9%, respectively. For
he main branch, all of them were AHA/ACC type
2/C lesions, lesion length was 19.7± 10.2mm, ref-
rence vessel diameter was 2.4± 0.5mm, and %DS
as 66.7± 15.6%. %DS of the side-branch ostium
as 47.7± 38.8% (Table 2).
n type (n = 46).
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Table 2 Lesion characteristics
Overall (n = 46)
Bifurcationlocation
LAD-DX (%) 57.1
LAD-LCX (%) 22.8
LCX-OM (%) 17.1
RCA (%) 2.9
Main branch
Lesion length (mm) 19.7± 10.2
Reference diameter (mm) 2.4± 0.5
MLD (mm) 0.7± 0.4
%DS 66.7± 15.6
ISR (%) 12 (33.3%)
ACC type B2/C (%) 100
Side branch
%DS 47.7± 38.8
LAD-DX, left anterior descending artery-diagonal branch;
Table 4 Overall clinical events (n = 39)
In hospital After discharge
Follow-up period (days) 184± 65
Death 0 0
MI 0 0
TLR PCI 0 1 (2.5%)
TLR CABG 0 0
Stent thrombosis 0 0
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CLCX, left circumﬂex artery; OM, obtuse margin; RCA, right
coronary artery; MLD, minimal lumen diameter; %DS, %
diameter stenosis; ISR, in-stent restenosis.
Procedural results
Table 3 shows the procedural results. The side-
branch procedure was performed by balloon (83.7%)
and T or modiﬁed T stenting (16.3%). Final in-
stent MLD and %DS of the main branch were
2.3± 0.6mm and 18.6± 12.3%. After the proce-
dure, mean side-branch %DS was 50.5%. Overall,
the ﬁnal kissing balloon technique was performed
in 53.4%.
Clinical outcomesTable 4 shows the clinical outcomes. With regard to
in-hospital clinical events, there were no cases of
death, stent thrombosis, or MI. The mean follow-
up period in all of the patients was 184± 65 days;
Table 3 Procedural results
Overall (n = 46)
Mainbranch
In-stent ﬁnal MLD (mm) 2.3± 0.6
In-segment ﬁnal MLD (mm) 2.0± 0.5
In-stent ﬁnal %DS 18.6± 12.3
In-segment ﬁnal %DS 28.8± 14.7
Side branch
Final %DS 50.5± 34.7
Side-branch procedure
Balloon (%) 83.7
T or modiﬁed T stenting (%) 16.3
Final KBT (%) 53.4
KBT, kissing balloon technique; %DS, % diameter stenosis;
MLD, minimal lumen diameter.
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mMI, myocardial infarction; TLR, target lesion revascular-
ization; PCI, percutaneous coronary intervention; CABG,
coronary artery bypass grafting.
here were no deaths, MI or stent thrombosis. There
as only one (2.5%) TLR lesion.
ngiographic follow-up
able 5 shows the angiographic results at follow-
p. Twenty-ﬁve lesions (including 5 LMT bifurcation
esions, 6 LCX-OM lesions, 13 LAD-Dx lesions, and 1
CA lesion) were analyzed quantitatively. Accord-
ng to the Duke classiﬁcation types C, D, and F
ifurcation values were 16.0%, 28.0% and 12.0%,
espectively. The side branches were treated with
alloon only. The mean follow-up period was
89.9± 61.4 days. Post-procedural %DS of the side
ranch (47.2± 34.4%) was similar to that at follow-
p (46.4± 24.1%).
iscussion
linical outcomes
ince the advent of the bare metal stent, the
reatment of coronary bifurcation lesions has
epresented a challenging area in interventional
ardiology [15]. Al Suwaidi et al. [1] randomized
31 patients with bifurcation lesions into a side-
ranch stenting (SS) group that received a bare
etal stent or a side-branch ballooning (SB) group,
Table 5 Angiographic follow-up (n = 25)
Main branch
Pre %DS 72.0 ± 18.7
In-segment ﬁnal %DS 28.8 ± 14.7
In-stent ﬁnal %DS 18.6 ± 12.3
In-segment follow-up %DS 29.6 ± 15.8
In-stent follow-up %DS 16.8 ± 15.5
Side branch
Pre %DS 43.8 ± 37.9
Final %DS 47.2 ± 34.4
Follow-up %DS 46.4 ± 24.1
Mean follow-up 190± 61days. %DS, % diameter stenosis.
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Table 6 Side-branch analysis by QCA
Colombo et al. [10] Pan et al. [12] Steigen et al. [11] Fukuoka University
Number of patients 22 47 151 25
LMT bifurcation lesion (%) 0 6 2 20
Pre %DS 64.7± 11.2 64± 13 46± 26 43.8± 37.9
Post %DS 11.7± 7.7 21± 17 34± 23 47.2± 34.4
Follow-up %DS 13.1± 7.8 28± 16 31± 22 46.4± 24.1
Follow-up period 6.4 months 11 months 8 months 190± 61days
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RKBT (%) 81.8 6
%DS, percent diameter stenosis; KBT, kissing balloon technique
nd compared the 1 year clinical outcomes between
he two groups. They found no signiﬁcant differ-
nces in death, QMI, or TLR between the two
roups. Yamashita et al. [2] also randomized 92
atients with bifurcation lesions into an SS group
ith BMS and an SB group and compared the clin-
cal outcomes at 6 months after the procedure.
hey found no signiﬁcant difference between the
wo groups with regard to the angiographic resteno-
is rate, TLR rate, or major adverse cardiac events
MACE) at a 6-month follow-up. However, the rate
f in-hospital MACE in the SS group was higher than
hat in the SB group (13% vs. 0%, p < 0.05), and
hey concluded that stenting both vessels did not
mprove the clinical outcome compared to the SB
trategy. These previous reports found no evidence
hat stenting of both branches offers an advan-
age over stenting of the main branch alone with
BMS. The introduction of DES has led to a dra-
atic increase in the number of patients treated
ercutaneously. However, for many interventionists
t is still difﬁcult to decide upon the most appro-
riate strategies for bifurcation lesions. Colombo
t al. [10] randomized 85 patients with bifurcation
nto two groups (stenting of both branches or stent-
ng of the main branch with provisional stenting of
he side branch) and found no signiﬁcant difference
n the restenosis rate of the main branch between
he two groups. However, three patients showed
tent thrombosis (3.5%), and they were all in the
S group. Based on these results, they concluded
hat SS did not improve the clinical results com-
ared to SB, even with the DES. In our study, there
ere no deaths after follow-up for 184± 65 days.
he clinical results of provisional stenting for the
ide branch in this study were similar to those in
revious studies, and seem to be acceptable.CA analysis for the side branch
e reviewed conventional ﬁndings of provisional
tenting for the side branch for comparison with
ur results (Table 6). Colombo et al. [10], Pan et al.32 51.4
T, left main trank.
12] and Steigen et al. [11] showed results similar
o those in our study, with no increase in %DS of
he SB during the follow-up period. There are a few
ossible mechanisms for the lack of a change in %DS
f a side branch during the follow-up period. One is
hat the thrombus and the small dissection may be
mproved at follow-up CAG. Another is the shifted
laque just after the procedure may not increase
t the follow-up period.
imitations
he major limitation of this study is that the
on-comparative design provides no information
egarding whether a strategy of provisional stent-
ng with SES is superior to a complex strategy.
nstead, we compared our results to those in previ-
us studies. The small number of patients is also an
mportant limitation of this study. In addition, the
esults of provisional stenting of side-branch stent-
ng of side branch might differ according to the size
f side branch.
onclusion
rovisional stenting for the side branch using a
irolimus-eluting stent is acceptable for the treat-
ent of bifurcation lesions. The %DS of the side
ranch remained unchanged over time after PCI.
s this study is the non-comparative design, large-
cale comparative studies are needed before any
eﬁnitive conclusions can be reached.
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